New Delhi, Oct. 21 -- Fortis Healthcare shares have suffered a sharp correction over 34% after climbing to around Rs.1,100 in October 2025, and over 25% in 3 months, but the decline could be setting up a potential technical rebound.

Choice Equity Broking's Sumeet Bagadia sees buying interest emerging near a crucial support zone around Rs.750, with the stock's technical indicators suggesting that selling pressure may be approaching an extreme.

Choice has recommended buying Fortis shares at Rs.794, with a target price of Rs.892 and a stop-loss at Rs.745.

"After peaking around Rs.1,100 in late 2025, the stock underwent a significant correction and has now approached a crucial horizontal demand zone of Rs.750. This zone presents an importa...